Incidence, Risk Factors, and Outcome of Tumor Lysis Syndrome in Hospitalized Children (1–12 Years) with Malignancy
Indian Journal of Medical and Paediatric Oncology · 14.02.2025
DOI: 10.1055/s-0044-1801768 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Medical and Paediatric Oncology, erschienen am 14.02.2025. Verfasst von Vinay Kumar und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Oncological emergencies such as tumor lysis syndrome (TLS) can strike before or during the start of chemotherapy. TLS is an important cause of death in children with malignancies. Understanding the risk factors and timely management can prevent mortality in these children.
Objectives
We performed this study to determine the incidence and risk factors for TLS in hospitalized children (1–12 years old) with malignancy and assess the outcomes in terms of the need for renal replacement therapy, residual kidney dysfunction, and death. Materials and Methods A prospective observational cohort study was performed for 18 months, and newly diagnosed children with malignancy aged 1 to 12 years with TLS were enrolled. They were followed to assess risk factors for TLS and their outcome.
Results
TLS was strongly correlated to the white blood cell count and spleen size at presentation. Uric acid was the most common parameter affected. Most patients developed TLS on day 1 of chemotherapy initiation.
Conclusion
Total leucocyte count (≥50,000 mm3) and spleen size more than 3 cm below the costal margin are associated with a higher risk of developing TLS and can be closely followed up for the development of TLS. The use of rasburicase lowers the incidence of TLS and the complications associated with raised uric acid levels.
Zitieren
APA
Kumar, V., Singh, A., Goel, N., Dawar, R., & Sharma, S. (2025). Incidence, Risk Factors, and Outcome of Tumor Lysis Syndrome in Hospitalized Children (1–12 Years) with Malignancy. Indian Journal of Medical and Paediatric Oncology. https://doi.org/10.1055/s-0044-1801768
Vancouver
Kumar V, Singh A, Goel N, Dawar R, Sharma S. Incidence, Risk Factors, and Outcome of Tumor Lysis Syndrome in Hospitalized Children (1–12 Years) with Malignancy. Indian Journal of Medical and Paediatric Oncology. 2025. doi:10.1055/s-0044-1801768
BibTeX
@article{Kumar2025,
author = {Kumar, Vinay and Singh, Amitabh and Goel, Neha and Dawar, Rajni and Sharma, Shobha},
title = {Incidence, Risk Factors, and Outcome of Tumor Lysis Syndrome in Hospitalized Children (1–12 Years) with Malignancy},
journal = {Indian Journal of Medical and Paediatric Oncology},
year = {2025},
doi = {10.1055/s-0044-1801768}
}
EUVIMED